Bioburden and sterility testing of IVD products
03 Dec 2021

Microbiological contamination can affect the safety, effectiveness, and time for in vitro diagnostic (IVD) products to reach the market. Ensuring the safety of such end-use products is of the utmost importance and having a bioburden and sterility testing program in place is one step to ensure product safety and quality.

In this webinar, you will learn about applicable regulations, an overview of methods, the development of a risk-based sampling plan, and the available services to guide you through selecting the best test for your needs.

Join this webinar to find out more about:

  • Bioburden and sterility testing methods
  • Regulatory guidelines
  • Selecting the proper testing solution

Who Should Attend

  • IVD assay R&D scientists
  • IVD research scientists
  • IVD manufacturing scientists
  • QA/QC personnel

Merck